Polar Asset Management Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-83,400
Closed -$8.5M 1016
2023
Q2
$8.5M Buy
+83,400
New +$8.5M 0.15% 160